Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
private placement isn't bad so long if it is used for expansion purpose and is issued at reasonable price. importantly, still got investors willing to take it, it implies that its still attractive. it doesn't have to bother anyway abt issuing through right issue, by which its cost is comparatively higher. this co got its own r&d, apparently not bad la. in comparison with other counterparts, it's considered a bit undervalue with its steady financial status. be patient.